These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 1676563

  • 1. Natural course of Graves' disease after subtotal thyroidectomy and management of patients with postoperative thyroid dysfunction.
    Kuma K, Matsuzuka F, Kobayashi A, Hirai K, Fukata S, Tamai H, Miyauci A, Sugawara M.
    Am J Med Sci; 1991 Jul; 302(1):8-12. PubMed ID: 1676563
    [Abstract] [Full Text] [Related]

  • 2. Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease.
    Mori Y, Matoba N, Miura S, Sakai N, Taira Y.
    World J Surg; 1992 Jul; 16(4):647-52; discussion 652-3. PubMed ID: 1357830
    [Abstract] [Full Text] [Related]

  • 3. Postoperative changes in thyrotropin-binding inhibitory immunoglobulin level in patients with Graves' disease: is subtotal thyroidectomy a suitable therapeutic option for patients of childbearing age with Graves' disease?
    Sugino K, Ito K, Ozaki O, Mimura T, Iwasaki H, Wada N.
    World J Surg; 1999 Jul; 23(7):727-31. PubMed ID: 10390595
    [Abstract] [Full Text] [Related]

  • 4. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K, Yamazaki K, Yamada E, Kanaji Y, Miura M, Obara T.
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [Abstract] [Full Text] [Related]

  • 5. Changes in thyroid function and immunological parameters long after subtotal thyroidectomy for Graves' disease.
    Kasuga Y, Kobayashi S, Fujimori M, Shingu K, Asanuma K, Hama Y, Ito K, Maruyama M, Amano J.
    Eur J Surg; 1998 Mar; 164(3):173-8. PubMed ID: 9562276
    [Abstract] [Full Text] [Related]

  • 6. Retrospective analysis of prognostic factors affecting the thyroid functional status after subtotal thyroidectomy for Graves' disease.
    Okamoto T, Fujimoto Y, Obara T, Ito Y, Aiba M.
    World J Surg; 1992 Mar; 16(4):690-5; discussion 695-6. PubMed ID: 1413838
    [Abstract] [Full Text] [Related]

  • 7. Changes in thyrotropin receptor antibody after subtotal thyroidectomy in Graves' disease: comparison with the degree of lymphocytic infiltration in the thyroid.
    Cho BY, Oh SK, Shong YK, Kim SE, Yoo HY, Lee HK, Koh CS, Min HK.
    Autoimmunity; 1990 Mar; 8(2):143-7. PubMed ID: 1983330
    [Abstract] [Full Text] [Related]

  • 8. Follow-up evaluation of patients with Graves' disease treated by subtotal thyroidectomy and risk factor analysis for post-operative thyroid dysfunction.
    Sugino K, Mimura T, Toshima K, Iwabuchi H, Kitamura Y, Kawano M, Ozaki O, Ito K.
    J Endocrinol Invest; 1993 Mar; 16(3):195-9. PubMed ID: 8099920
    [Abstract] [Full Text] [Related]

  • 9. Factors affecting thyroid function after subtotal thyroidectomy for Graves' disease: case control study by remnant-weight matched-pair analysis.
    Ozaki O, Ito K, Mimura T, Sugino K, Ito K.
    Thyroid; 1997 Aug; 7(4):555-9. PubMed ID: 9292942
    [Abstract] [Full Text] [Related]

  • 10. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
    Tamaki H, Amino N, Aozasa M, Mori M, Tanizawa O, Miyai K.
    J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
    [Abstract] [Full Text] [Related]

  • 11. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment.
    Tamai H, Hirota Y, Kasagi K, Matsubayashi S, Kuma K, Iida Y, Konishi J, Okimura MC, Walter RM, Kumagai LF.
    J Clin Endocrinol Metab; 1987 Apr; 64(4):718-22. PubMed ID: 2434520
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. NIS mRNA expression level in resected thyroid tissue as a marker of postoperative hypothyroidism after subtotal thyroidectomy in patients with Graves' disease.
    Goto A, Uchino S, Noguchi S, Wakiya S, Watanabe Y, Murakami T, Matsuura B, Onji M.
    Endocr J; 2008 Mar; 55(1):73-81. PubMed ID: 18187871
    [Abstract] [Full Text] [Related]

  • 14. Changes in the thyroid function of Graves' disease patients treated by subtotal thyroidectomy.
    Sugino K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Yano Y, Uruno T, Akaishi J, Suzuki A, Masaki C, Ito K.
    Endocr J; 2012 Mar; 59(12):1115-20. PubMed ID: 22971989
    [Abstract] [Full Text] [Related]

  • 15. Hyperthyroidism with potent thyroid-stimulation-blocking antibodies and negative thyroid-stimulating antibodies after subtotal thyroidectomy for Graves' disease with follicular thyroid carcinoma.
    Sugimoto M, Nakamura S, Hattori J, Yamada T, Horiya Y, Hara S, Shima H.
    Intern Med; 1993 Mar; 32(3):266-8. PubMed ID: 8101110
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Short-term triiodothyronine in prevention of temporary hypothyroidism after subtotal thyroidectomy for Graves' disease.
    Wilkin TJ, Gunn A, Isles TE, Crooks J, Beck JS.
    Lancet; 1979 Jul 14; 2(8133):63-6. PubMed ID: 87965
    [Abstract] [Full Text] [Related]

  • 18. Preoperative change of thyroid stimulating hormone receptor antibody level: possible marker for predicting recurrent hyperthyroidism in patients with Graves' disease after subtotal thyroidectomy.
    Sugino K, Mimura T, Ozaki O, Iwasaki H, Wada N, Matsumoto A, Ito K.
    World J Surg; 1996 Sep 14; 20(7):801-6; discussion 806-7. PubMed ID: 8678954
    [Abstract] [Full Text] [Related]

  • 19. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
    Takasu N, Oshiro C, Akamine H, Komiya I, Nagata A, Sato Y, Yoshimura H, Ito K.
    J Endocrinol Invest; 1997 Sep 14; 20(8):452-61. PubMed ID: 9364248
    [Abstract] [Full Text] [Related]

  • 20. The effect of subtotal thyroidectomy with propranolol preparation on antibody activity in Graves' disease.
    Steel NR, Taylor JJ, Young ET, Farndon JR, Holcombe M, Kendall-Taylor P.
    Clin Endocrinol (Oxf); 1987 Jan 14; 26(1):97-106. PubMed ID: 3802553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.